GUARDANT HEALTH, INC. Net Income
GUARDANT HEALTH, INC. (GH) reported Net Income of -$120.14 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2026-07-30
- GUARDANT HEALTH, INC. net income (loss) attributable to parent for the quarter ending 2026-06-30 was -$120.14M.
- GUARDANT HEALTH, INC. net income (loss) attributable to parent for the quarter ending 2026-03-31 was -$112.08M.
- GUARDANT HEALTH, INC. net income (loss) attributable to parent for the quarter ending 2025-12-31 was -$128.52M.
- GUARDANT HEALTH, INC. net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$92.72M.
- GUARDANT HEALTH, INC. net income (loss) attributable to parent for fiscal 2019 was -$75.65M.
- GUARDANT HEALTH, INC. net income (loss) attributable to parent for fiscal 2018 was -$85.06M.
- GUARDANT HEALTH, INC. net income (loss) attributable to parent for fiscal 2017 was -$83.22M.
- GUARDANT HEALTH, INC. net income (loss) attributable to parent for fiscal 2016 was -$46.14M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month | Net Income (Loss) Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$120.14M 10-Q · filed 2026-07-30 | -$232.22M 10-Q · filed 2026-07-30 | -$360.73M derived: sum of 3 quarters · filed 2026-07-30 | -$453.46M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2026-03-31 | -$112.08M 10-Q · filed 2026-05-07 | -$240.59M derived: sum of 2 quarters · filed 2026-05-07 | -$333.32M derived: sum of 3 quarters · filed 2026-05-07 | -$433.22M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-12-31 | -$128.52M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-28 | -$221.24M derived: sum of 2 quarters · filed 2026-04-28 | -$321.14M derived: sum of 3 quarters · filed 2026-07-30 | -$416.30M DEF 14A · filed 2026-04-28 | -$416.28M 10-K · filed 2026-02-19 |
| 2025-09-30 | -$92.72M 10-Q · filed 2025-10-29 | -$192.62M derived: sum of 2 quarters · filed 2026-07-30 | -$287.78M 10-Q · filed 2025-10-29 | -$398.82M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-06-30 | -$99.90M 10-Q · filed 2026-07-30 | -$195.06M 10-Q · filed 2026-07-30 | -$306.09M derived: sum of 3 quarters · filed 2026-07-30 | -$413.85M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-03-31 | -$95.16M 10-Q · filed 2026-05-07 | -$206.19M derived: sum of 2 quarters · filed 2026-05-07 | -$313.95M derived: sum of 3 quarters · filed 2026-05-07 | -$416.57M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | -$111.03M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-28 | -$218.79M derived: sum of 2 quarters · filed 2026-04-28 | -$321.42M derived: sum of 3 quarters · filed 2026-04-28 | -$436.40M DEF 14A · filed 2026-04-28 | -$436.37M 10-K · filed 2025-02-20 |
| 2024-09-30 | -$107.75M 10-Q · filed 2025-10-29 | -$210.38M derived: sum of 2 quarters · filed 2025-10-29 | -$325.37M 10-Q · filed 2025-10-29 | -$512.36M derived: sum of 4 quarters · filed 2026-04-28 | |
| 2024-06-30 | -$102.63M 10-Q · filed 2025-07-30 | -$217.61M 10-Q · filed 2025-07-30 | -$404.61M derived: sum of 3 quarters · filed 2026-04-28 | -$490.71M derived: sum of 4 quarters · filed 2026-04-28 | |
| 2024-03-31 | -$114.98M 10-Q · filed 2025-04-30 | -$301.98M derived: sum of 2 quarters · filed 2026-04-28 | -$388.08M derived: sum of 3 quarters · filed 2026-04-28 | -$460.85M derived: sum of 4 quarters · filed 2026-04-28 | |
| 2023-12-31 | -$186.99M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-28 | -$273.10M derived: sum of 2 quarters · filed 2026-04-28 | -$345.87M derived: sum of 3 quarters · filed 2026-04-28 | -$479.40M DEF 14A · filed 2026-04-28 | -$479.45M 10-K · filed 2024-02-22 |
| 2023-09-30 | -$86.10M 10-Q · filed 2024-11-06 | -$158.87M derived: sum of 2 quarters · filed 2024-11-06 | -$292.41M 10-Q · filed 2024-11-06 | -$432.35M derived: sum of 4 quarters · filed 2026-04-28 | |
| 2023-06-30 | -$72.77M 10-Q · filed 2024-08-07 | -$206.30M 10-Q · filed 2024-08-07 | -$346.25M derived: sum of 3 quarters · filed 2026-04-28 | -$508.24M derived: sum of 4 quarters · filed 2026-04-28 | |
| 2023-03-31 | -$133.53M 10-Q · filed 2024-05-09 | -$273.48M derived: sum of 2 quarters · filed 2026-04-28 | -$435.47M derived: sum of 3 quarters · filed 2026-04-28 | -$664.90M derived: sum of 4 quarters · filed 2026-04-28 | |
| 2022-12-31 | -$139.95M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-28 | -$301.94M derived: sum of 2 quarters · filed 2026-04-28 | -$531.37M derived: sum of 3 quarters · filed 2026-04-28 | -$654.60M DEF 14A · filed 2026-04-28 | -$654.59M 10-K · filed 2024-02-22 |
| 2022-09-30 | -$161.99M 10-Q · filed 2023-11-06 | -$391.43M derived: sum of 2 quarters · filed 2023-11-06 | -$514.65M 10-Q · filed 2023-11-06 | ||
| 2022-06-30 | -$229.43M 10-Q · filed 2023-08-03 | -$352.66M 10-Q · filed 2023-08-03 | |||
| 2022-03-31 | -$123.23M 10-Q · filed 2023-05-09 | ||||
| 2021-12-31 | -$384.80M DEF 14A · filed 2026-04-28 | -$384.77M 10-K · filed 2024-02-22 | |||
| 2019-12-31 | -$75.65M 10-K · filed 2020-03-02 | ||||
| 2018-12-31 | -$25.12M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$49.58M derived: sum of 2 quarters · filed 2020-03-02 | -$85.06M 10-K · filed 2020-03-02 | ||
| 2018-09-30 | -$24.46M 10-Q · filed 2018-11-19 | -$59.94M 10-Q · filed 2018-11-19 | |||
| 2017-12-31 | -$15.06M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$43.65M derived: sum of 2 quarters · filed 2020-03-02 | -$83.22M 10-K · filed 2020-03-02 | ||
| 2017-09-30 | -$28.59M 10-Q · filed 2018-11-19 | -$68.16M 10-Q · filed 2018-11-19 | |||
| 2016-12-31 | -$46.14M 10-K · filed 2019-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |